NCT01104246View on ClinicalTrials.gov

Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Hypogonadism
Interventions
DRUG

Testerone Transdermal System

Transdermal testosterone applied daily for 4 weeks

Trial Locations (3)

33025

Watson investigational site, Miramar

68184

Watson investigational site, Omaha

78209

Watson investigational site, San Antonio

Sponsors
All Listed Sponsors
lead

Watson Pharmaceuticals

INDUSTRY

NCT01104246 - Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men | Biotech Hunter | Biotech Hunter